美国卫生系统和Regeneron发射Truveta基因组项目,为医学研究建立一个庞大的遗传数据库。 US health systems and Regeneron launch Truveta Genome Project to build a massive genetic database for medical research.

美国主要卫生系统和Regenenron制药公司启动了Truveta基因组项目,目的是通过对数百万志愿者例行测试遗留的生物群进行排序,从而创建最大的基因数据库。 Leading US health systems and Regeneron Pharmaceuticals have launched the Truveta Genome Project, aiming to create the largest genetic database by sequencing leftover biospecimens from millions of volunteers' routine tests. 这些数据将与已查明的医疗记录联系起来,用于AI驱动的研究,以加速药物发现,优化临床试验,改进疾病预防和诊断。 Linked to de-identified medical records, the data will be used for AI-driven research to accelerate drug discovery, optimize clinical trials, and improve disease prevention and diagnosis. 微软Azure将为项目提供云服务。 Microsoft Azure will provide cloud services for the project.